| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.06 | 0.3 |